Tetrabutylammonium Fluoride → 5-(6-((2R,6S)-2,6-dimethylmorpholino)-7-fluoro-5-(hydroxymethyl)benzo[d]isoxazol-3-yl)-1,3,4-oxadiazol-2(3H)-one
反応式
[Si]([O:18][CH2:19][C:20]1[C:21]([N:36]2[CH2:41][C@H:40]([CH3:42])[O:39][C@H:38]([CH3:43])[CH2:37]2)=[C:22]([F:35])[C:23]2[O:27][N:26]=[C:25]([C:28]3[O:32][C:31](=[O:33])[NH:30][N:29]=3)[C:24]=2[CH:34]=1)(C(C)(C)C)(C1C=CC=CC=1)C1C=CC=CC=1.CCCC[N+](CCCC)(CCCC)CCCC.[F-]>C1COCC1>[CH3:42][C@@H:40]1[CH2:41][N:36]([C:21]2[C:20]([CH2:19][OH:18])=[CH:34][C:24]3[C:25]([C:28]4[O:32][C:31](=[O:33])[NH:30][N:29]=4)=[N:26][O:27][C:23]=3[C:22]=2[F:35])[CH2:37][C@H:38]([CH3:43])[O:39]1参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
5-(5-((tert-butyldiphenylsilyloxy)methyl)-6-((2R,6S)-2,6-dimethylmorpholino)-7-fluorobenzo[d]isoxazol-3-yl)-1,3,4-oxadiazol-2(3H)-one (Intermediate 208, 490 mg, 0.81 mmol) in 10 ml of THF was treated with TBAF (1M in THF; 1626 μl, 1.63 mmol) at room temperature for 16 hours. Reaction quenched with aq ammonium chloride solution and Extracted with ethyl acetate. Crude product purified on column (50-80% etoac in hexanaes) to give 5-(6-((2R,6S)-2,6-dimethylmorpholino)-7-fluoro-5-(hydroxymethyl)benzo[d]isoxazol-3-yl)-1,3,4-oxadiazol-2(3H)-one (235 mg, 79%)
後処理
- customReaction
- customquenched with aq ammonium chloride solution
- extractionExtracted with ethyl acetate
- customCrude product purified on column (50-80% etoac in hexanaes)
出典と根拠
- ORDレコード
- ord-b3ab6c34b5a7440cb7718fcfa1649574
- 出典データセット
- uspto-grants-2014_02
- 特許番号
- US08658641B2
反応ノート
読み込み中…